Anticancer activity of panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting β-catenin signalling

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 11, 2009, Pages 1074-1078

  Bi, Xiuli ^a   Zhao, Yuqing ^b   Fang, Wenfeng ^a,c   Yang, Wancai ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

catenin signalling; 20(S) 25 OCH3 PPD; Cancer

Indexed keywords

20 25 METHOXYL DAMMARANE 3BETA,12BETA,20 TRIOL; ANTINEOPLASTIC AGENT; BETA CATENIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DAMMARANE DERIVATIVE; MYC PROTEIN; PANAX NOTOGINSENG EXTRACT; PPD 25; SAPOGENIN; T CELL FACTOR PROTEIN; T CELL FACTOR PROTEIN 4; UNCLASSIFIED DRUG; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG INHIBITION; DRUG ISOLATION; HUMAN; HUMAN CELL; LUNG CANCER; PANAX NOTOGINSENG; PLANT LEAF; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRITERPENES; WNT PROTEINS;

EID: 70449474610     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05203.x     Document Type: Article

References (30)

1. Kelloff GJ, Lippman SM, Dannenberg AJ et al. Progress in chemoprevention drug development. The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer: A plan to move forward. Clin. Cancer Res. 2006 12 : 3661 3697.
2. van de Wetering M, Sancho E, Verweij C et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002 111 : 241 250.
3. Mazieres J, He B, You L, Xu Z, Jablons DM. Wnt signaling in lung cancer. Cancer Lett. 2005 222 : 1 10.
4. Turashvili G, Bouchal J, Burkadze G, Kolar Z. Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 2006 73 : 213 223.
5. Lee HC, Kim M, Wands JR. Wnt/Frizzled signaling in hepatocellular carcinoma. Front. Biosci. 2006 11 : 1901 1915.
6. Terry S, Yang X, Chen MW, Vacherot F, Buttyan R. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. J. Cell Biochem. 2006 99 : 402 410. (Pubitemid 44435558)
7. Clement G, Jablons DM, Benhattar J. Targeting the Wnt signaling pathway to treat Barrett's esophagus. Expert Opin. Ther. Targets 2007 11 : 375 389.
8. Herbst A, Kolligs FT. Wnt signaling as a therapeutic target for cancer. Methods Mol. Biol. 2007 361 : 63 91.
9. Luo J, Chen J, Deng ZL et al. Wnt signaling and human diseases: What are the therapeutic implications? Lab. Invest. 2007 87 : 97 103.
10. Yang W, Velcich A, Mariadason J et al. p21 (WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo. Cancer Res. 2001 61 : 6297 6302.
11. Han A, Song Z, Tong C et al. Sulindac suppresses β-catenin expression in human cancer cells. Eur. J. Pharmacol. 2008 583 : 26 31.
12. Rhule A, Navarro S, Smith JR, Shepherd DM. Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells. J. Ethnopharmacol. 2006 106 : 121 128.
13. Chen FD, Wu MC, Wang HE et al. Sensitization of a tumor, but not normal tissue, to the cytotoxic effect of ionizing radiation using Panax notoginseng extract. Am. J. Chin. Med. 2001 29 : 517 524.
14. Lam SK, Ng TB. Isolation of a novel thermolabile heterodimeric ribonuclease with antifungal and antiproliferative activities from roots of the sanchi ginseng Panax notoginseng. Biochem. Biophys. Res. Commun. 2001 285 : 419 423.
15. Wang CZ, Luo X, Zhang B et al. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemother. Pharmacol. 2007 60 : 69 79.
16. Wang CZ, Xie JT, Zhang B et al. Chemopreventive effects of Panax notoginseng and its major constituents on SW480 human colorectal cancer cells. Int. J. Oncol. 2007 31 : 1149 1156.
17. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother. Pharmacol. 2007 59 : 589 601.
18. Zhao Y, Wang W, Han L et al. Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3β, 12β,20-triol[20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng. Med. Chem. 2007 3 : 51 60.
19. 2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. Am. J. Pathol. 2007 171 : 297 303.
20. Han A, Tong C, Hu D, Bi X, Yang W. A direct protein-protein interaction is involved in th esuppression of β-catenin transcription by retinoid x receptor a in colorectal cancer cells. Cancer Biol. Ther. 2008 7 : 454 459.
21. Sherr CJ. Principles of tumor suppression. Cell 2004 116 : 235 246.
22. Hu D, Fang W, Han A et al. c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/β-catenin signaling through GSK3β pathway. Carcinogenesis 2008 29 : 2317 2324.
23. Zhang YG, Zhang HG, Zhang GY et al. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Clin. Exp. Pharmacol. Physiol. 2008 35 : 1238 1244.
24. Chan RY, Chen WF, Dong A et al. Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J. Clin. Endocrinol. Metab. 2002 87 : 3691 3695.
25. Ng TB. Pharmacological activity of sanchi ginseng (Panax notoginseng). J. Pharm. Pharmacol. 2006 58 : 1007 1019.
26. Ueda M, Gemmill RM, West J et al. Mutations of the β- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br. J. Cancer 2001 85 : 64 8.
27. Hommura F, Furuuchi K, Yamazaki K et al. Increased expression of β-catenin predicts better prognosis in nonsmall cell lung carcinomas. Cancer 2002 94 : 752 758.
28. Fodde R, Edelmann W, Yang K et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl Acad. Sci. USA 1994 91 : 8969 8973.
29. Velcich A, Yang W, Heyer J et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002 295 : 1726 1729.
30. Narayanan BA. Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr. Cancer Drug Targets 2006 6 : 711 727.